Literature DB >> 10488218

Optimizing culture of Chlamydia pneumoniae by using multiple centrifugations.

J M Pruckler1, N Masse, V A Stevens, L Gang, Y Yang, E R Zell, S F Dowell, B S Fields.   

Abstract

Three methods for the recovery of Chlamydia pneumoniae from spiked nasopharyngeal and blood specimens, including extended culture and additional centrifugations, were compared. Additional centrifugations and a 7-day culture time resulted in a 500- to 5, 000-fold increase in the number of detectable inclusion-forming units.

Mesh:

Year:  1999        PMID: 10488218      PMCID: PMC85582          DOI: 10.1128/JCM.37.10.3399-3401.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

Review 1.  Infections caused by Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

Review 2.  Chronic infections and coronary heart disease: is there a link?

Authors:  J Danesh; R Collins; R Peto
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

3.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

4.  A novel method for isolation of Chlamydia pneumoniae by treatment with trypsin or EDTA.

Authors:  Y Kazuyama; S M Lee; K Amamiya; F Taguchi
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Origin of HEp-2 cells used for culture of chlamydiae.

Authors:  G E Kenney
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Evaluation of culture conditions used for isolation of Chlamydia pneumoniae.

Authors:  M Maass; U Harig
Journal:  Am J Clin Pathol       Date:  1995-02       Impact factor: 2.493

7.  Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract.

Authors:  K H Wong; S K Skelton; Y K Chan
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

8.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

9.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

10.  Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR.

Authors:  C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

View more
  4 in total

1.  Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells.

Authors:  J B Mahony; S Chong; B K Coombes; M Smieja; A Petrich
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Maria L Tondella; Deborah F Talkington
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

3.  Centrifugation of human lung epithelial carcinoma a549 cells up-regulates interleukin-1beta gene expression.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; M Lucia Tondella; Deborah F Talkington
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

4.  Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae.

Authors:  Maria Lucia C Tondella; Deborah F Talkington; Brian P Holloway; Scott F Dowell; Karyn Cowley; Montse Soriano-Gabarro; Mitchell S Elkind; Barry S Fields
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.